When might these drugs become available? Not for several years: they still need to go through large (Phase III) trials, and problems could be found in these larger trials that would kill the development of one or more of the SGLT2 inhibitors. But assuming that the Phase III trials succeed, we can expect that sometime in the future, the next class of diabetes drugs will be the SGLT2 inhibitors.
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
